Patents Assigned to Yissum Research Developmemt Company of the Hebrew University of Jerusalem
  • Patent number: 8399708
    Abstract: The invention relates to the use of valnoctamide (VCD) for the treatment of bipolar disorder and in particular for the treatment of the manic phase of the bipolar disorder.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: March 19, 2013
    Assignee: Yissum Research Developmemt Company of the Hebrew University of Jerusalem
    Inventors: Meir Bialer, Boris Yagen